Coleen Glessner insider trades
Open-market stock purchases and sales by Coleen Glessner, EVP, Quality & Ethics, and CPL at Emergent BioSolutions Inc, from SEC Form 4 filings since Apr 8, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 8, 2026 | EBS Emergent BioSolutions Inc | Sold (not open market) | $16.1K |
| Apr 29, 2026 | EBS Emergent BioSolutions Inc | Bought (not open market) | — |
| Mar 5, 2026 | EBS Emergent BioSolutions Inc | Sold (not open market) | $69.2K |
| Mar 3, 2026 | EBS Emergent BioSolutions Inc | Bought (not open market) | — |
| Mar 1, 2026 | EBS Emergent BioSolutions Inc | Sold (not open market) | $2.6K |
| Feb 6, 2026 | EBS Emergent BioSolutions Inc | Sold (not open market) | $315K |
| Feb 6, 2026 | EBS Emergent BioSolutions Inc | Sold (not open market) | $31.1K |
| Oct 7, 2025 | EBS Emergent BioSolutions Inc | Sold | $306K |
Companies traded
- EBS Emergent BioSolutions Inc: 1 sale, last Jun 8, 2026